Valuation: Getinge AB

Market Cap 56.08B 5.83B 5.09B 4.69B 4.36B 8.29B 557B 8.38B 21.83B 273B 21.91B 21.42B 952B P/E 2026 *
19.8x
P/E 2027 * 16.9x
Enterprise Value 64.74B 6.73B 5.88B 5.42B 5.03B 9.57B 643B 9.67B 25.2B 315B 25.29B 24.73B 1,099B EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.71x
Free-Float
78.61%
Yield 2026 *
2.45%
Yield 2027 * 2.69%
1 week+5.35%
Current month+5.15%
1 month+9.22%
3 months+6.36%
6 months-6.00%
Current year-6.65%
1 week 17.8
Extreme 17.795
18.92
1 month 17.05
Extreme 17.05
18.92
3 years 14.2
Extreme 14.2
21.19
5 years 14.2
Extreme 14.2
43.02
10 years 0
Extreme 0
43.02
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO - 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
-1.24%+5.35%+10.21%+20.12% 5.87B
-0.11%+0.51%+26.75%-5.65% 12.53B
-3.42%+0.19%+62.47%+33.86% 6.36B
-1.92%+7.37% - - 4.38B
-0.09%+7.29%-33.27%+6.84% 4.05B
-0.56%+3.40%-25.83%-24.47% 3.91B
+0.70%+12.25%-2.20%-58.45% 1.99B
+0.78%+5.22%+27.22%+249.40% 1.88B
-0.60%-0.07%+59.73%-7.81% 1.55B
+0.49%+11.06%-13.14%-46.46% 1.3B
Average -0.53%+5.55%+12.44%+18.60% 4.22B
Weighted average by Cap. -0.83%+4.16%+17.21%+12.03%

Financials

2026 *2027 *
Net sales 34.99B 3.64B 3.18B 2.93B 2.72B 5.17B 347B 5.23B 13.62B 170B 13.67B 13.36B 594B 36.79B 3.83B 3.34B 3.08B 2.86B 5.44B 365B 5.5B 14.32B 179B 14.38B 14.05B 625B
Net income 2.82B 293M 256M 236M 219M 416M 27.96B 421M 1.1B 13.71B 1.1B 1.08B 47.85B 3.3B 343M 300M 276M 256M 487M 32.73B 493M 1.28B 16.05B 1.29B 1.26B 56.01B
Net Debt 8.66B 900M 786M 724M 672M 1.28B 85.91B 1.29B 3.37B 42.12B 3.38B 3.31B 147B 6.66B 693M 605M 557M 517M 984M 66.11B 996M 2.59B 32.41B 2.6B 2.54B 113B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
-
Date Price Change
06/07/26 €18.66 -1.24%
03/07/26 €18.90 +2.11%
02/07/26 €18.51 +1.23%
01/07/26 €18.28 +1.73%
30/06/26 €17.97 +0.98%
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
205.90SEK
Average target price
226.70SEK
Spread / Average Target
+10.10%

Quarterly revenue - Rate of surprise